Aida Pharmaceuticals, Inc. (AIDA) Research

Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.

Market snapshot

Symbol
AIDA
Price
$0.00
Day change
0.00%
Market cap
$8.1K
P/E ratio
0.00x
52-week range
0.0002-0.0003
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Bloomios, Inc. (BLMS)
  • Better Therapeutics, Inc. (BTTX)
  • CanaQuest Medical Corp. (CANQF)
  • CEN Biotech, Inc. (CENBF)
  • MJ Holdings, Inc. (MJNE)
  • Panacos Pharmaceuticals, Inc. (PANC)
  • Sentry Petroleum Ltd (SPLM)
  • Anbc, Inc. (SYUP)

Open Aida Pharmaceuticals, Inc. (AIDA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.